Cytosorbents Corp Share Price OTC Bulletin Board
Equities
CTSO
US23283X1072
Advanced Medical Equipment & Technology
Sales 2024 * | 41.33M 3.28B | Sales 2025 * | 47.76M 3.79B | Capitalization | 45.16M 3.59B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.59B | Net income 2025 * | -9M -715M | EV / Sales 2024 * | 1.09 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.95 x |
P/E ratio 2024 * |
-2.31
x | P/E ratio 2025 * |
-4.09
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Vincent Capponi
PSD | President | 66 | 24/04/02 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 13/07/15 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 23/07/08 |
Edward Jones
BRD | Director/Board Member | 75 | 31/03/07 |
1st Jan change | Capi. | |
---|---|---|
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |